Intravenous diazoxide in acute poststreptococcal glomerulonephritis

Area of Science:

• Nephrology
• Cardiology
• Pharmacology

Background:

• Hypertension is a common complication of acute poststreptococcal glomerulonephritis.
• Effective and safe antihypertensive agents are needed for this specific patient population.

Purpose of the Study:

• To evaluate the efficacy and safety of diazoxide in treating hypertension secondary to acute poststreptococcal glomerulonephritis.

Main Methods:

• Twenty-six patients with hypertension secondary to acute poststreptococcal glomerulonephritis received rapid intravenous infusion of diazoxide.
• Blood pressure (systolic and diastolic) was measured before and 5 minutes after administration.

Main Results:

• A significant reduction in average systolic pressure (159 to 122 mm Hg, 23% decrease) and diastolic pressure (104 to 71 mm Hg, 32% decrease) was observed within 5 minutes.
• No hypotensive episodes occurred; mild nausea was an occasional side effect.
• Transient increases in blood glucose levels were noted, but remained below 155 mg/dl.

Conclusions:

• Diazoxide is a safe and effective intravenous antihypertensive agent for managing acute hypertension in patients with poststreptococcal glomerulonephritis.
• The rapid onset of action and favorable safety profile make diazoxide a valuable therapeutic option.